Fig. 6

Sensitivity analysis of incremental cost-effectiveness ratio for the ≥150 incidence threshold. The bars show the distance between the low or high estimate and the best estimate obtained from probabilistic analysis (€ 55,911; see Table 2); parameters are sorted from high to low absolute difference to the probabilistic estimate; labels outside of bars denote the upper or lower-bound parameter value investigated